STOCK TITAN

Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc.

Aspire rebrands as Aspire-Lakewood Holdings while keeping its Nasdaq listing, ticker, and stockholder rights unchanged.

(Moderate)
(Very Positive)
Tags

Aspire Biopharma Holdings (ASBP) announced a corporate name change to Aspire-Lakewood Holdings, Inc., effective upon filing a Certificate of Amendment with the Delaware Secretary of State.

The board of directors and stockholders approved the change under Section 242 of the Delaware General Corporation Law. The company said the new name and holding company structure reflect its evolution following the acquisition of Dura Control Systems Corp. and its broader, high-volume diversified operations.

The company’s common stock will continue to trade on the Nasdaq Capital Market under the same ticker, and stockholder rights, listings, and existing stock certificates remain unchanged, with no action required by investors.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Historical Context

2 past events · Latest: Aug 10
2 events
  1. Aug 10

    Acquisition completion

    24h Move
    +0.8%

    Completed Dura acquisition established the expanded operating platform cited in the name change

  2. Jun 12

    Acquisition agreement

    24h Move
    -17.3%

    Dura agreement established the automotive diversification underlying the holding company structure

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

certificate of amendment, holding company structure, book-entry form, mechatronic actuators
4 terms
certificate of amendment regulatory
"effective upon the filing of a Certificate of Amendment to the Company's Certificate"
A certificate of amendment is an official filing that updates a company’s founding documents—its legal “rulebook” that sets share structure, voting rules, name and basic purpose. Think of it like changing the blueprint of a building: small changes are paperwork, big ones can alter who owns how much and who controls decisions. Investors watch these filings because they can affect share counts, voting power, dilution and company value.
holding company structure financial
"Adopting a holding company structure better aligns our corporate architecture"
A holding company structure is an arrangement where one parent company owns controlling stakes in multiple separate businesses (subsidiaries) while the parent itself usually handles ownership, financing and strategy rather than day‑to‑day operations. For investors, this matters because it can isolate risk, concentrate cash flows or liabilities in particular units and make it easier to sell or reorganize parts of the enterprise—like a landlord owning several rental properties rather than managing each apartment directly—so you must assess both the parent’s balance sheet and the health of its subsidiaries.
book-entry form financial
"Stockholders holding shares in book-entry form or through a bank"
A book-entry form is an electronic record showing ownership of securities instead of a paper certificate; think of it like a bank account ledger that notes who owns shares. It matters to investors because it makes buying, selling and transferring securities faster, safer and cheaper by reducing paperwork, loss or forgery risk, and enabling easier settlement through brokers or a central depository.
mechatronic actuators technical
"portfolio that includes mechatronic actuators, human machine interfaces"
Mechatronic actuators are devices that combine mechanical parts, electronic sensors and circuits, and control software to create precise motion or force in a machine — think of a motor plus built‑in brains that move parts on command. They matter to investors because they are core components in automation, robotics, vehicles, and industrial equipment where improved accuracy, speed, energy use and reliability can change a manufacturer’s product performance and cost structure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ESTERO, FL / ACCESS Newswire / September 8, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced that it has changed its corporate name from "Aspire Biopharma Holdings, Inc." to "Aspire-Lakewood Holdings, Inc." The name change is effective upon the filing of a Certificate of Amendment to the Company's Certificate of Incorporation with the Secretary of State of the State of Delaware. The Company's ticker symbol, "ASBP", will remain unchanged.

Kraig Higginson, Chief Executive Officer of Aspire-Lakewood Holdings, commented, "Transitioning our corporate identity to Aspire-Lakewood Holdings, Inc. marks a pivotal milestone in our evolution. Following our recent acquisition of Dura Control Systems Corp., Aspire has successfully scaled into a high-volume, diversified enterprise. Adopting a holding company structure better aligns our corporate architecture with this expanded business focus."

The name change was approved by the Company's board of directors (the "Board") and stockholders in accordance with Section 242 of the General Corporation Law of the State of Delaware. The name change reflects the Company's evolving business strategy and operations.

The Company's common stock will continue to trade on The Nasdaq Capital Market. In connection with the name change, the Company's trading symbol on Nasdaq will remain the same ("ASPB"). Stockholders holding shares in book-entry form or through a bank, broker, or other nominee are not required to take any action in connection with the name change.

The name change does not affect the rights of the Company's stockholders. The Company's shares of common stock will continue to be listed and traded on Nasdaq and will not be affected by the name change. No action is required by current stockholders with respect to the name change, and stock certificates reflecting the prior corporate name will continue to be valid.

About Aspire-Lakewood Holdings, Inc.

Aspire-Lakewoood Holdings, Inc.'s subsidiary, Dura Control Systems Corp. (DCSC), is a leading designer and manufacturer of highly engineered automotive and industrial control systems that combine mechanical engineering, electronics and computer science to provide intelligent, automated systems for vehicle electrification, safety, lightweighting, and sustainability. DCSC maintains a strong powertrain agnostic product portfolio that includes mechatronic actuators, human machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The Company operates 11 manufacturing facilities globally and serves as a tier one automotive supplier to major OEMs and other industrial firms.

About Lakewood & Company, LLC

Lakewood & Company, LLC is a multi-stage investment firm founded in 2005 to complete global private equity investments in businesses that operate in the Industrial and Business Services sectors. Lakewood's partners provide a track record of success as investors and operating executives and as a result provide an operational focus to invest in opportunities that have a hands-on, collaborative partnership with management. Lakewood professionals represent decades of investment and operating experience from diverse backgrounds in industrials and business services and sources capital to complete its investments on a deal-by-deal basis with investors from family offices, UHNWI, and institutions.

For more information, please visit www.aspirebiolabs.com

Aspire-Lakewood Holdings, Inc.

Contact

PCG Advisory
Kevin McGrath
+1-646-418-7002
kevin@pcgadvisory.com

Safe Harbor Statement

Certain statements made in this communication are "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as "estimate," "projects," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "would," "should," "future," "propose," "potential," "target," "goal," "objective," "outlook" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire-Lakewood's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

SOURCE: Aspire Biopharma Holdings, Inc.



View the original press release on ACCESS Newswire

FAQ

Do Aspire-Lakewood stockholders need to take any action because of the name change?

No action is required by current stockholders. Shares held in book-entry form or through a bank, broker, or other nominee are unaffected, and existing stock certificates bearing the prior corporate name remain valid.

Does the name change affect Aspire-Lakewood’s Nasdaq listing or ticker symbol?

The company’s common stock will continue to be listed and traded on the Nasdaq Capital Market, and the trading symbol will remain the same, so the name change does not affect the listing or ticker.

Why is Aspire changing its name to Aspire-Lakewood Holdings?

The company stated that the new name and adoption of a holding company structure better align its corporate identity and architecture with its expanded business focus after the acquisition of Dura Control Systems Corp. and its scale-up into a high-volume, diversified enterprise.

What business does Aspire-Lakewood’s subsidiary Dura Control Systems Corp. conduct?

Dura Control Systems Corp. designs and manufactures highly engineered automotive and industrial control systems that integrate mechanical engineering, electronics, and computer science for vehicle electrification, safety, lightweighting, and sustainability. Its powertrain-agnostic portfolio includes mechatronic actuators, human–machine interfaces, industrial cables, and cable control systems, supported by over 310 patents and 11 manufacturing facilities serving major automotive OEMs and other industrial customers.

Who is Lakewood & Company, and how is it described?

Lakewood & Company is described as a multi-stage investment firm founded in 2005 that focuses on private equity investments in Industrial and Business Services companies. It emphasizes an operational, hands-on, and collaborative partnership approach with management and sources capital on a deal-by-deal basis from family offices, ultra-high-net-worth individuals, and institutions.

Where can investors find more information about Aspire-Lakewood Holdings?

For more information, investors are directed to visit the company’s website at www.aspirebiolabs.com.

Keep reading